NCT00269386 - Clarithromycin in Active Crohn's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

December 31, 2006

Study Completion Date

May 31, 2007

Conditions

Crohn's Disease

Interventions

DRUG

Clarithromycin

Clarithromycin S/R 1g once daily April 2004 - Clarithromycin S/R (Klaricid XL) ceased to be abailable and subsequent patients will receive standard Clarithromycin 500mg bd

DRUG

Placebo

Trial Locations (1)

L7 8XP

Royal Liverpool University Hospital, Liverpool